Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Microneedle-mediated delivery of Coptis chinensis-derived nanovesicles orchestrating antibacterial and macrophage reprogramming for comprehensive wound healing

Xu KM., Lin JQ., Zhuo XX., Xiao L., Zhao YJ., Zhang C.

Animal Study on Chronic Wound, Chronic Inflammation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Nanobiotechnology (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41749279
PMCID
PMC13041469
DOI
10.1186/s12951-026-04218-3
Citations
1

Abstract (original English)

Conventional antibiotic treatments for infected wounds often inadequately regulate the complex inflammatory cascade and fail to sufficiently promote tissue regeneration, leading to delayed healing and potential secondary tissue damage. Consequently, designing multifunctional biomaterials capable that can simultaneously exert antibacterial, anti-inflammatory, and pro-regenerative actions remains a critical challenge in wound management. In this study, we developed a soluble microneedle (MN) array loaded with nanovesicles derived from Coptis chinensis (CDVs), which serves as an integrated tri-functional platform to synergistically accelerate healing of infected wounds. The CDVs were effectively encapsulated within sodium alginate-based microneedles, with calcium ions introduced to reinforce structural crosslinking. Upon penetration into the wound bed, the MNs facilitated deep tissue delivery and sustained release of CDVs, which triggered a ROS burst inside bacteria, resulting in membrane disruption and bacterial eradication. Both in vitro and in vivo evaluations confirmed that the released CDVs promoted macrophage polarization toward the M2 phenotype and enhanced glucose uptake via the AMPK/mTOR pathway, thereby remodeling the inflammatory microenvironment and stimulating angiogenesis and tissue regeneration. Notably, in vivo wound healing assays demonstrated that the MN-mediated

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MacrophagesAnimalsMiceCoptisAnti-Bacterial AgentsWound HealingRAW 264.7 CellsPercutaneous Collagen InductionMicroneedle Drug Delivery

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research